Skip to main content

Animations

MJFF Publications

6731 - 6740 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2015
  • 2011
  • 2008
  • 2011
  • 2016
  • 2009
  • 2018
  • 2012
  • 2019
  • Summary Details
    OPEN
    Title: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12728
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Stochastic electrotransport selectively enhances the transport of highly electromobile molecules
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1510133112
    Citation Count: 237
  • Summary Details
    OPEN
    Title: BAX inhibitor‐1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2011.318
    Citation Count: 112
  • Summary Details
    OPEN
    Title: UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nature07181
    Citation Count: 685
  • Summary Details
    OPEN
    Title: Regulation of Physiologic Actions of LRRK2: Focus on Autophagy
    Journal Name: Neurodegenerative Diseases
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000332599
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww180
    Citation Count: 77
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 527
  • Summary Details
    OPEN
    Title: Development of an optogenetic toolkit for neural circuit dissection in squirrel monkeys
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-24362-7
    Citation Count: 29
  • Summary Details
    OPEN
    Title: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244
    Citation Count: 325
  • Summary Details
    OPEN
    Title: Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy Controls
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2019-0315
    Citation Count: 35
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.